RELATED: In another blow to ‘herd immunity,’ study shows decline of COVID-19 antibodies after a few weeksThose early volunteers developed what are called neutralizing antibodies in their bloodstream -- molecules key to blocking infection -- at levels comparable to those found in people who survived COVID-19, the research team reported in the New England Journal of Medicine.Advertisement“This is an essential building block that is needed to move forward with the trials that could actually determine whether the vaccine does protect against infection,” said Dr.
Lisa Jackson of the Kaiser Permanente Washington Research Institute in Seattle, who led the study.There’s no guarantee but the government hopes to have results around the end of the.